According to the WHO, the programme is the first vaccine injury compensation mechanism operating on an international scale. It covers all 92 low- and middle-income countries and economies that are eligible for support from the COVAX Facility until 30 June 2022.
The compensation programme will offer all eligible individuals a ‘fast, fair, robust and transparent’ process for gaining compensation in the rare event that they experience a serious side effect associated with a COVAX-distributed vaccine.
The COVAX programme will provide a no-fault lump sum compensation in full and final settlement of any claims, the WHO said in a statement.
This strategy aims to reduce the need for making use of law courts, which could potentially be a lengthy and costly process…